Boston University
Development of mouse models of multisystemic histiocytosis-like disease with bone involvement
Abstract
dc:description.abstractHistiocytosis features the aberrant functions of macrophages, osteoclasts, and other cells of hematopoietic origin. It has an extensive range of phenotypic presentations involving single organ or multiple organs. The bone phenotype of histiocytosis, the most prominent in juvenile cases, is in most cases aggressive and lethal. Current treatments available are broad and have limited effectiveness. The BRAF gene is an oncogene involved in the mitogen activated protein kinase (MAPK) pathway. A point mutation in the BRAF gene resulting in replacement of valine (V) to glutamine (E) at the aminoacidic position 600 results in constitutive activity generally common in cancers and Langerhans cell histiocytosis. Exploration of more specific treatment methods for histiocytosis targets the BRAF V600E mutation. Here we work on developing and testing new mouse models that express BrafV600E mutations. Further analysis of the fluorescent labeling efficiency of tamoxifen inducible mouse model will be completed before proceeding to inducing histiocytosis-like disease with bone involvement in mice.
Degree
thesis:*- Name thesis:degree_name
- Master of Science
- Level thesis:degree_level
- masters
- Discipline thesis:degree_discipline
- Medical Sciences
- Grantor
- Boston University
- Year dc:date.issued
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Deroly, Darah Rose-Merlie
- Advisor dc:contributor.advisor
-
- Bragdon, Beth
Subjects
dc:subject × 9Rights
dc:rights- Statement dc:rights
-
- Attribution 4.0 International
- Licence dc:rights.uri
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/2144/52272